Antibody drug conjugates may help personalise radiotherapy for patients with cancer

Many types of cancer become drug resistant, making them difficult to treat. Researchers with University of California San Diego School of Medicine and Moores Cancer Center have identified a strategy to selectively sensitise certain cancer cells to radiation therapy that may improve tumour control and reduce treatment-related side effects.
Medical Express